At present, no effective therapy is available for metastatic pancreatic cancer. This proposal seeks to overcome this impasse by employing a novel approach employing a cancer-specific conditionally replication competent adenovirus that expresses a therapeutic cytokine, IFN-? or mda-7/IL-24 (a cancer terminator virus (CTV)), in combination with an ultrasound (US) contrast agent and US waves. These studies are based on the observations that IFN-? and mda-7/IL-24 displays selective anti-pancreatic cancer activity, potent 'bystander'anti-tumor activity, anti-angiogenic activity. Based on profound multifunctional, selective anti-cancer activities of mda-7/IL-24, this gene has been evaluated in a Phase I clinical trial in patients with advanced cancers, not including pancreatic cancer, by repeat intratumoral injections with a non-replicating adenovirus (Ad) expressing mda-7/IL-24 (Ad.mda-7;INGN 241). This therapeutic approach was safe and resulted in significant clinical activity. Restrictions of Ad-based therapies include rapid degradation and clearance by the immune system, thus limiting systemic applications. By using US contrast agents (microbubbles) we will achieve both specificity of action as well as protection of the viral vectors from inactivation. Additionally, the gas filled microspheres effectively lower the energy threshold for cavitation allowing diagnostic transducers operating within the energy levels mandated by the FDA to be used for drug/gene delivery. In the sonification zone the microbubbles undergo cavitation, destroying the bubbles and releasing their contents, creating small shockwaves that increase cell permeability. This has been shown to increase transcapillary passage of macromolecules or nanospheres co-delivered by the microbubbles in experimental animals. In principle, the present approach should allow efficient CTV delivery and may evoke a cure in both primary and distant mestastatic pancreatic cancer, which will be tested in immune incompetent animal models. Successful accomplishment of these studies will pave the way for future clinical trials.

Public Health Relevance

The present study seeks to develop an effective therapy for pancreatic cancer that employs cancer-specific apoptosis-inducing cytokines, IFN-? or mda-7/IL-24, delivered by a conditionally replication competent adenovirus, a cancer terminator virus (CTV), in combination with ultrasound contrast agents and ultrasound waves. This novel approach will permit efficient systemic delivery of the CTV to tumors, offering the potential to develop a 'cure'for both localized and metastatic pancreatic cancer. Successful achievement of the objectives of the present proposal will provide for rapid translation into the clinic as a new and potentially effective therapy for metastatic pancreatic cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
5R03CA140024-02
Application #
7913010
Study Section
Special Emphasis Panel (ZRG1-ONC-U (92))
Program Officer
Tandon, Pushpa
Project Start
2009-08-14
Project End
2013-07-31
Budget Start
2010-08-01
Budget End
2013-07-31
Support Year
2
Fiscal Year
2010
Total Cost
$71,000
Indirect Cost
Name
Marshall University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
036156615
City
Huntington
State
WV
Country
United States
Zip Code
25701
Connor, Avonne E; Visvanathan, Kala; Baumgartner, Kathy B et al. (2016) Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study. Breast Cancer Res Treat 157:167-78
Wolf, M Allison; Claudio, Pier Paolo (2014) Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin. Nutr Cancer 66:285-94
De Carlo, Flavia; Witte, Theodore R; Hardman, W Elaine et al. (2013) Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy. PLoS One 8:e69760
Aimola, Pierpaolo; Carmignani, Marco; Volpe, Anna Rita et al. (2012) Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. PLoS One 7:e33647
Nande, Rounak; Di Benedetto, Altomare; Aimola, Pierpaolo et al. (2012) Targeting a newly established spontaneous feline fibrosarcoma cell line by gene transfer. PLoS One 7:e37743
Gossman, Michael S; Das, Indra J; Sharma, Subhash C et al. (2011) A novel phantom model for mouse tumor dose assessment under MV beams. Health Phys 101:746-53
Kelly, Sarah E; Di Benedetto, Altomare; Greco, Adelaide et al. (2010) Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. PLoS One 5:e10035
Vogiatzi, Paraskevi; Claudio, Pier Paolo (2010) Efficacy of abiraterone acetate in post-docetaxel castration-resistant prostate cancer. Expert Rev Anticancer Ther 10:1027-30
Greco, Adelaide; Di Benedetto, Altomare; Howard, Candace M et al. (2010) Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach. Mol Ther 18:295-306